Trials / Completed
CompletedNCT05619562
Clinical Significance of Circulating Tumour Cells in Resectable Lung Cancer Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 166 (actual)
- Sponsor
- The Institute of Molecular and Translational Medicine, Czech Republic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine whether the presence of circulating/disseminated tumour cells (CTCs/DTCs) in the blood and bone marrow of the resectable lung cancer (NSCLC) patients is a negative prognostic factor, and to find correlations with other clinical/pathological disease characteristics.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Device for CTC/DTC detection | The CTCs/DTCs will be detected and counted in peripheral blood, tumour draining blood and bone marrow samples. |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2013-04-01
- Completion
- 2015-12-01
- First posted
- 2022-11-17
- Last updated
- 2022-11-17
Locations
1 site across 1 country: Czechia
Source: ClinicalTrials.gov record NCT05619562. Inclusion in this directory is not an endorsement.